Joe Palca
Stories
-
Health
All You Wanted To Know About Coronavirus Vaccine Science But Were Afraid To Ask
Some of the technology behind coronavirus vaccine development dates back to the first vaccines; other techniques are much newer. Here are eight top strategies scientists are pursuing.
-
Health
Early Results Show Benefit Of Steroid For Very Sick COVID-19 Patients
A low-cost anti-inflammatory drug appears to reduce the risk of death in patients with COVID-19. The promising result comes from a large study of therapies being conducted in the U.K.
-
Health
Cows' Antibodies May Help Humans During Coronavirus Crisis
A South Dakota biotech company is using cows to create antibodies that could then be used for disease prevention or treatment. The cows have been given the genes to make a human-like immune system.
-
Health
FDA Withdraws Emergency Use Authorization For Hydroxychloroquine
Emergency use authorization makes it easier for doctors to use a drug in a manner not specifically approved by the Food and Drug Administration. The FDA granted these drugs this status in March.
-
Health
No Evidence Hydroxychloroquine Is Helpful In Preventing COVID-19, Study Finds
A study of more than 800 health workers, first responders and others finds that taking hydroxychloroquine to prevent COVID-19 is no better than a placebo in preventing the illness.
-
Politics
What Happened Today: Boston Marathon Is Cancelled, Vaccine Questions
NPR's science correspondent answers listener questions about the pace and process needed to develop a viable coronavirus vaccine.
-
Health
What People Can Learn From The Discovery Of A Polio Vaccine
People in the 1950s anxiously waited for scientists to come up with ways to protect children from polio. The road to a polio vaccine might contain some lessons for today's health crisis.
-
Science
What Happened Today: House Passes A New Relief Package, Vaccine Questions
NPR's science correspondent answers listener questions about the latest in the hunt for a coronavirus vaccine.
-
Health
New Coronavirus Vaccine Candidate Shows Promise In Early, Limited Trial
Cambridge, Mass.-based Moderna, Inc., is reporting preliminary data suggesting its COVID-19 vaccine is safe, and appears to be triggering an immune response in test subjects.
-
Health
Coronavirus Vaccine Study Yields Positive Preliminary Results
Initial results from a study of a COVID-19 vaccine suggest it is safe, and capable of generating the kind of immune response that may protect patients from getting the disease.